The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ranibizumab     Quarter: 2016Q3

Total Records: 133     Number of Pages: 7

DRUGNAME PT EventCount
Ranibizumab Macular hole 3
Ranibizumab Malaise 3
Ranibizumab Migraine with aura 3
Ranibizumab Open angle glaucoma 3
Ranibizumab Osteoarthritis 3
Ranibizumab Pain 3
Ranibizumab Sciatica 3
Ranibizumab Transient ischaemic attack 3
Ranibizumab Urinary tract infection 3
Ranibizumab Uveitis 3
Ranibizumab Vitreous detachment 3
Ranibizumab Waldenstrom's macroglobulinaemia 3
Ranibizumab Weight decreased 3
Ranibizumab Abnormal sensation in eye 2
Ranibizumab Acute kidney injury 2
Ranibizumab Acute myocardial infarction 2
Ranibizumab Choroidal haemangioma 2
Ranibizumab Conjunctival oedema 2
Ranibizumab Conjunctivitis 2
Ranibizumab Dizziness 2

Total Records: 133     Number of Pages: 7